These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release. Hasenhuetl PS, Bhat S, Freissmuth M, Sandtner W. Mol Pharmacol; 2019 Mar; 95(3):303-312. PubMed ID: 30567955 [Abstract] [Full Text] [Related]
4. The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter. Kern C, Erdem FA, El-Kasaby A, Sandtner W, Freissmuth M, Sucic S. J Biol Chem; 2017 Mar 03; 292(9):3603-3613. PubMed ID: 28104804 [Abstract] [Full Text] [Related]
5. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Rickli A, Hoener MC, Liechti ME. Eur Neuropsychopharmacol; 2015 Mar 03; 25(3):365-76. PubMed ID: 25624004 [Abstract] [Full Text] [Related]
6. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Wall SC, Gu H, Rudnick G. Mol Pharmacol; 1995 Mar 03; 47(3):544-50. PubMed ID: 7700252 [Abstract] [Full Text] [Related]
7. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH. Neuropharmacology; 2005 Nov 03; 49(6):811-9. PubMed ID: 16185723 [Abstract] [Full Text] [Related]
8. Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII. Steinkellner T, Montgomery TR, Hofmaier T, Kudlacek O, Yang JW, Rickhag M, Jung G, Lubec G, Gether U, Freissmuth M, Sitte HH. J Neurosci; 2015 May 27; 35(21):8258-71. PubMed ID: 26019340 [Abstract] [Full Text] [Related]
9. The N terminus of monoamine transporters is a lever required for the action of amphetamines. Sucic S, Dallinger S, Zdrazil B, Weissensteiner R, Jørgensen TN, Holy M, Kudlacek O, Seidel S, Cha JH, Gether U, Newman AH, Ecker GF, Freissmuth M, Sitte HH. J Biol Chem; 2010 Apr 02; 285(14):10924-38. PubMed ID: 20118234 [Abstract] [Full Text] [Related]
10. A quantitative model of amphetamine action on the 5-HT transporter. Sandtner W, Schmid D, Schicker K, Gerstbrein K, Koenig X, Mayer FP, Boehm S, Freissmuth M, Sitte HH. Br J Pharmacol; 2014 Feb 02; 171(4):1007-18. PubMed ID: 24251585 [Abstract] [Full Text] [Related]
11. Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters. Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE. J Pharmacol Exp Ther; 2012 Apr 02; 341(1):251-62. PubMed ID: 22271821 [Abstract] [Full Text] [Related]
12. Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function. Bhat S, Niello M, Schicker K, Pifl C, Sitte HH, Freissmuth M, Sandtner W. Elife; 2021 Jun 01; 10():. PubMed ID: 34061030 [Abstract] [Full Text] [Related]
17. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. Xie Z, Westmoreland SV, Miller GM. J Pharmacol Exp Ther; 2008 May 01; 325(2):629-40. PubMed ID: 18310473 [Abstract] [Full Text] [Related]